Prognostic value of serum beta 2 microglobulin in primary gastric lymphoma.

@article{Avils1991PrognosticVO,
  title={Prognostic value of serum beta 2 microglobulin in primary gastric lymphoma.},
  author={Agust{\'i}n Avil{\'e}s and Jos{\'e} C. D{\'i}az-Maqueo and Lorena Rodr{\'i}guez and E. L{\'o}pez. Garc{\'i}a and Renaldo Guzm{\'a}n and Alejandra Talavera},
  journal={Hematological oncology},
  year={1991},
  volume={9 2},
  pages={115-21}
}
Sixty-eight previously untreated patients with primary gastric non-Hodgkin's lymphoma (NHL) available for analysis, were entered in a study in which the prognostic significance of serum beta 2 microglobulin levels were evaluated. The serum beta 2 microglobulin was the most significant prognostic factor. Patients with high levels (greater than 3.5 micrograms/mL) had a relapse-free survival (RFS) of 36 months, while the median RFS has not been reached in patients with normal levels (p less than 0… CONTINUE READING

From This Paper

Figures and tables from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 20 references

The role of surgery in the multimodal treatment of primary gastric non-Hodgkin’s lymphoma

E. Ascali
Cancer • 1990

A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 1989

Chemotherapy following surgery for stages IE and IIE non-Hodgkin's lymphoma of the gastrointestinal tract.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 1988

Similar Papers

Loading similar papers…